| Home | E-Submission | Sitemap | Contact Us |  
top_img
J Korean Soc Emerg Med > Volume 15(2); 2004 > Article
Journal of The Korean Society of Emergency Medicine 2004;15(2): 75-79.
Clinical Aspects and Management of a Herbicide Containing Glufosinate Ammonium and Surfactant
In Woo Hwang, Tae Oh Jeong, Young Ho Jin, Jae Baek Lee
1Department of Emergency Medicine, Medical School, Chonbuk National University, Jeonju, Korea. emmd@lycos.co.kr
2Institute for Medical Science, Medical School, Chonbuk National University, Jeonju, Korea.
ABSTRACT
PURPOSE:
The purpose of this study was to assess the clinical aspects of glufosinate poisoning and to present basic data for proper management.
METHODS:
A retrospective study by chart review was done on 20 patient who had ingested glufosinate ammonium and who presented to the emergency medical center of Chunbuk National University Hospital from January 1997 through June 2003.
RESULTS:
We found that the poisoned patients expressed a gradually progressing depression of mentality, recent memory disturbance, convulsion, hypotension, or fever. The onset time was variable and ranged between 12 and 23 hours. There was a close connection between the ingested amount and the severity, but not the blood ammonia level. CONCILUSION: In acute oral Basta poisoning, patients develop a variety of clinical signs; some are even asymptomatic while others die, The mortality was 26%, so we should make a specialized study of glufosinate ammonium.
Key words: Poisoning, Herbicides
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
2,083
View
117
Download
Related article
Clinical Considerations of Intoxication Caused by a Herbicide Containing Glufosinate Ammonium: 6 Cases Analysis  1998 December;9(4)
Editorial Office
The Korean Society of Emergency Medicine
TEL: +82-62-226-1780   FAX: +82-62-224-3501   E-mail: 0012194@csuh.co.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Emergency Medicine.                 Developed in M2PI